Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19717648rdf:typepubmed:Citationlld:pubmed
pubmed-article:19717648lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:19717648lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:19717648lifeskim:mentionsumls-concept:C0040648lld:lifeskim
pubmed-article:19717648lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:19717648lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:19717648lifeskim:mentionsumls-concept:C1511545lld:lifeskim
pubmed-article:19717648lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:19717648pubmed:issue18lld:pubmed
pubmed-article:19717648pubmed:dateCreated2009-10-30lld:pubmed
pubmed-article:19717648pubmed:abstractTextCCAAT/enhancer-binding protein beta (C/EBPbeta), also known as nuclear factor-interleukin-6 (NF-IL6), is a transcription factor that plays an important role in the regulation of growth and differentiation of myeloid and lymphoid cells. Mice deficient in C/EBPbeta show impaired generation of B lymphocytes. We show that C/EBPbeta regulates transcription factors critical for proliferation and survival in multiple myeloma. Multiple myeloma cell lines and primary multiple myeloma cells strongly expressed C/EBPbeta, whereas normal B cells and plasma cells had little or no detectable levels of C/EBPbeta. Silencing of C/EBPbeta led to down-regulation of transcription factors such as IRF4, XBP1, and BLIMP1 accompanied by a strong inhibition of proliferation. Further, silencing of C/EBPbeta led to a complete down-regulation of antiapoptotic B-cell lymphoma 2 (BCL2) expression. In chromatin immunoprecipitation assays, C/EBPbeta directly bound to the promoter region of IRF4, BLIMP1, and BCL2. Our data indicate that C/EBPbeta is involved in the regulatory network of transcription factors that are critical for plasma cell differentiation and survival. Targeting C/EBPbeta may provide a novel therapeutic strategy in the treatment of multiple myeloma.lld:pubmed
pubmed-article:19717648pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19717648pubmed:languageenglld:pubmed
pubmed-article:19717648pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19717648pubmed:citationSubsetAIMlld:pubmed
pubmed-article:19717648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19717648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19717648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19717648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19717648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19717648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19717648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19717648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19717648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19717648pubmed:statusMEDLINElld:pubmed
pubmed-article:19717648pubmed:monthOctlld:pubmed
pubmed-article:19717648pubmed:issn1528-0020lld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:RoodmanG...lld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:JanzMartinMlld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:DörkenBerndBlld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:PalRekhaRlld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:Anagnostopoul...lld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:MilcarekChris...lld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:LentzschSuzan...lld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:GalsonDeborah...lld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:MaparaMarkus...lld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:GriesMargaret...lld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:LiShirongSlld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:BorghesiLisaLlld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:KardavaLelaLlld:pubmed
pubmed-article:19717648pubmed:authorpubmed-author:JöhrensKorinn...lld:pubmed
pubmed-article:19717648pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19717648pubmed:day29lld:pubmed
pubmed-article:19717648pubmed:volume114lld:pubmed
pubmed-article:19717648pubmed:ownerNLMlld:pubmed
pubmed-article:19717648pubmed:authorsCompleteYlld:pubmed
pubmed-article:19717648pubmed:pagination3890-8lld:pubmed
pubmed-article:19717648pubmed:dateRevised2010-11-1lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:meshHeadingpubmed-meshheading:19717648...lld:pubmed
pubmed-article:19717648pubmed:year2009lld:pubmed
pubmed-article:19717648pubmed:articleTitleC/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells.lld:pubmed
pubmed-article:19717648pubmed:affiliationDivision of Hematology/Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA.lld:pubmed
pubmed-article:19717648pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19717648pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:596entrezgene:pubmedpubmed-article:19717648lld:entrezgene
entrez-gene:1051entrezgene:pubmedpubmed-article:19717648lld:entrezgene
entrez-gene:639entrezgene:pubmedpubmed-article:19717648lld:entrezgene
entrez-gene:3662entrezgene:pubmedpubmed-article:19717648lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19717648lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19717648lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19717648lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19717648lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19717648lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19717648lld:pubmed